
C2i Genomics
C2i Genomics is the first company to develop the most comprehensive whole-genome monitoring of cancer recurrence and progression by analyzing subtle changes in the pattern of the tumor’s DNA.
0
0
0
Key Info
- 2019 Founded
- New York, New York, United States
- 66 Employees
- •••••••••
Team
Investments
There is no investment data on this organization.